Aflac Incorporated (NYSE:AFL) Shares Purchased by Adapt Wealth Advisors LLC

Adapt Wealth Advisors LLC raised its stake in Aflac Incorporated (NYSE:AFL) by 19.5% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,781 shares of the financial services provider’s stock after acquiring an additional 1,108 shares during the period. Adapt Wealth Advisors LLC’s holdings in Aflac were worth $606,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Eudaimonia Partners LLC boosted its position in Aflac by 234.6% during the 4th quarter. Eudaimonia Partners LLC now owns 10,448 shares of the financial services provider’s stock valued at $862,000 after purchasing an additional 7,325 shares during the period. Crossmark Global Holdings Inc. increased its holdings in shares of Aflac by 22.6% in the 4th quarter. Crossmark Global Holdings Inc. now owns 86,010 shares of the financial services provider’s stock worth $7,096,000 after acquiring an additional 15,855 shares during the period. Southeast Asset Advisors Inc. lifted its position in Aflac by 0.4% in the 4th quarter. Southeast Asset Advisors Inc. now owns 139,164 shares of the financial services provider’s stock valued at $11,481,000 after purchasing an additional 589 shares during the last quarter. Nordea Investment Management AB boosted its stake in Aflac by 6.7% during the 1st quarter. Nordea Investment Management AB now owns 1,806,475 shares of the financial services provider’s stock valued at $155,140,000 after purchasing an additional 113,226 shares during the period. Finally, Richard C. Young & CO. LTD. acquired a new position in shares of Aflac during the fourth quarter valued at $12,546,000. 67.44% of the stock is owned by institutional investors.

Aflac Trading Down 0.7 %

Shares of Aflac stock opened at $108.89 on Monday. The company has a market cap of $61.87 billion, a price-to-earnings ratio of 12.02, a PEG ratio of 2.61 and a beta of 0.95. Aflac Incorporated has a 1 year low of $73.79 and a 1 year high of $111.14. The company’s fifty day simple moving average is $99.12 and its 200-day simple moving average is $90.04. The company has a current ratio of 0.10, a quick ratio of 0.10 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.23. The company had revenue of $5.14 billion for the quarter, compared to analyst estimates of $4.10 billion. Aflac had a net margin of 28.35% and a return on equity of 16.22%. The business’s quarterly revenue was down .7% on a year-over-year basis. During the same period last year, the business posted $1.58 EPS. As a group, sell-side analysts expect that Aflac Incorporated will post 6.73 EPS for the current year.

Aflac Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, September 2nd. Shareholders of record on Wednesday, August 21st were issued a $0.50 dividend. The ex-dividend date was Wednesday, August 21st. This represents a $2.00 annualized dividend and a yield of 1.84%. Aflac’s dividend payout ratio (DPR) is 22.08%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on AFL. Jefferies Financial Group reduced their price target on shares of Aflac from $84.00 to $83.00 and set a “hold” rating for the company in a research note on Friday, June 28th. Bank of America increased their target price on Aflac from $108.00 to $115.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Piper Sandler boosted their price target on shares of Aflac from $95.00 to $100.00 and gave the company an “overweight” rating in a report on Friday, June 28th. Truist Financial raised their price objective on shares of Aflac from $82.00 to $100.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Finally, Barclays assumed coverage on Aflac in a report on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 target price for the company. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $92.50.

Insider Buying and Selling at Aflac

In other news, Director Thomas J. Kenny sold 2,000 shares of Aflac stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total transaction of $197,880.00. Following the sale, the director now owns 18,158 shares of the company’s stock, valued at approximately $1,796,552.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.90% of the company’s stock.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.